Sculptor Capital LP - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 102 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.

Quarter-by-quarter ownership
Sculptor Capital LP ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$488,000
-18.1%
725,6000.0%0.00%
-75.0%
Q1 2019$596,000
-48.6%
725,6000.0%0.00%
-50.0%
Q4 2018$1,160,000725,6000.01%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
NEA Management Company, LLC 25,243,865$16,913,0001.18%
SABBY MANAGEMENT, LLC 281,112$189,0000.24%
New Leaf Venture Partners, L.L.C. 402,118$271,0000.07%
WealthTrust Axiom LLC 134,585$90,0000.03%
EXCALIBUR MANAGEMENT CORP 51,000$34,0000.03%
Caption Management, LLC 748,200$503,0000.02%
Anson Funds Management LP 98,986$66,0000.02%
GSA CAPITAL PARTNERS LLP 210,474$142,0000.02%
Evercore Wealth Management, LLC 418,414$282,0000.01%
Gemmer Asset Management LLC 1,939$31,0000.01%
View complete list of AVEO PHARMACEUTICALS INC shareholders